Why sales of Eli Lilly’s Zepbound and Mounjaro fell short
Eli Lilly’s blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro posted weaker-than-expected sales for the third quarter, even as supply of both medicines has largely recovered from widespread shortages in the U.S. The reason for the disappointing sales, according […]
Why sales of Eli Lilly’s Zepbound and Mounjaro fell short Read More »